Product Images Tekturna

This is information regarding medication TEKTURNA 156HG, distributed by PHYSICIANS TOTAL CARE with NDC number 54868-5772-0. The lot number is 060 with an expiration date of 61/60. The manufacturer appears to be NOVARTIS.*

This is a prescription drug label for Tekturna tablets, distributed by Physicians Total Care. The drug has a strength of 306 milligrams and is packaged in a bottle with lot number 6600 and expiration date 61/60. The label also includes TSA and NDC numbers. The last line of text is not clear and seems to be a random combination of letters and numbers.*

This appears to be a table showing the impact of co-administered drugs on the pharmacokinetics (PK) of aliskiren, along with recommendations for dose adjustment. Certain drugs, such as Cyclosporine and Ketoconazole should be avoided. Other medications, such as Hydrochlorothiazide, Ramipril, and Metformin, do not require a dose adjustment. The table also displays a "Change relative to aliskiren alone" column, which may refer to the fold change observed in the presence of the co-administered drugs. However, one section of the text is not clearly readable.*

This text is an evaluation of the impact of aliskiren on the pharmacokinetics of co-administered drugs. It presents a table with various drugs classified into two categories - antihypertensives and others. The table shows the PK fold changes and 90% recommendations for each drug, as well as changes relative to the interacting drug alone. The conclusion is that most drugs do not require a dose adjustment when co-administered with aliskiren, except for indapamide, which should be monitored closely.*